Background Although malaria can be prevented with prophylaxis, it is diagnosed in over 100
Africa-region Peace Corps Volunteers annually. This suggests that prophylaxis non …

Despite inadequacy in preventing vivax malaria after travel, suppressive chemoprophylaxis
has dominated travel medicine strategy since the advent of chloroquine in 1946. The lethal …

The risk of malaria for travelers varies from region to region and depends on the intensity of
transmission, the duration of the stay in the area of endemicity, the style of travel, and the …

Background Poor compliance with chemoprophylaxis is a major contributing factor to the risk
of malaria in travelers. Pre-travel chemoprophylaxis may improve compliance by enabling …

ContextLong-term travelers, defined here as those traveling for periods of 6 months or
longer, face particular challenges regarding malaria prevention. Current guidelines for …

Background International travel is rapidly increasing worldwide, and the greatest increases
have occurred in tropical and subtropical areas. The aim of the survey was to investigate the …

Abstract Analysis of malaria imported into eight European countries from the Indian sub-
continent (ISC)(India, Pakistan, Bangladesh and Sri Lanka) led to a consensus statement on …

More Swedish residents travel to countries where they are at risk for contracting malaria,
hepatitis, and other serious travel-related diseases. To safeguard the public's health, it is …

Background There were 1,370 cases of imported malaria and six fatalities in the UK in 2008,
the majority of which were due to chloroquine‐resistant Plasmodium falciparum. Poor …

Since its introduction to the market in 1985, mefloquine has been used for malaria
chemoprophylaxis by more than 35 million travellers. In Europe, in 2014, the European …